Luis Menendez
Overview
Explore the profile of Luis Menendez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Llorian-Salvador M, Pevida M, Gonzalez-Rodriguez S, Lastra A, Fernandez-Garcia M, Hidalgo A, et al.
Fundam Clin Pharmacol
. 2016 Jan;
30(3):235-47.
PMID: 26820818
Chemokine CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), is a molecule that in addition to its well-established role in chemotaxis can also act as nociceptor sensitizer. The upregulation of...
12.
Llorian-Salvador M, Gonzalez-Rodriguez S, Lastra A, Fernandez-Garcia M, Hidalgo A, Menendez L, et al.
Basic Clin Pharmacol Toxicol
. 2015 Dec;
119(1):32-40.
PMID: 26663750
Chemokines are chemotactic cytokines whose involvement in nociceptive processing is being increasingly recognized. Based on the previous description of the involvement of CC chemokine receptor type 1 (CCR1) in pathological...
13.
Llorian-Salvador M, Pevida M, Fernandez-Garcia M, Lastra A, Obaya A, Cal S, et al.
Prostate
. 2014 Sep;
75(1):70-83.
PMID: 25263196
Background: Pain due to bone metastases of prostatic origin is a relevant clinical issue. We study here the nociceptive responses obtained in mice receiving the intratibial inoculation of RM1 prostate...
14.
Pevida M, Lastra A, Meana A, Hidalgo A, Baamonde A, Menendez L
Neuroscience
. 2013 Dec;
259:113-25.
PMID: 24316469
Although the expression of the chemokine receptor CCR1 has been demonstrated in several structures related to nociception, supporting the nociceptive role of chemokines able to activate it, the involvement of...
15.
Pevida M, Gonzalez-Rodriguez S, Lastra A, Garcia-Suarez O, Hidalgo A, Menendez L, et al.
Cell Mol Neurobiol
. 2013 Oct;
34(1):143-56.
PMID: 24122510
The hypernociceptive role played by the chemokine CCL2, and its main receptor, CCR2, in pathological settings is being increasingly recognized. We aimed to characterize the involvement of spinal CCL2 in...
16.
Pevida M, Lastra A, Hidalgo A, Baamonde A, Menendez L
Brain Res Bull
. 2013 Apr;
95:21-7.
PMID: 23562605
The antineoplastic paclitaxel induces a sensory neuropathy that involves the spinal release of neuroinflammatory mediators and activation of glial cells. Although the chemokine CCL2 can evoke glial activation and its...
17.
Pevida M, Gonzalez-Rodriguez S, Lastra A, Hidalgo A, Menendez L, Baamonde A
Naunyn Schmiedebergs Arch Pharmacol
. 2012 Sep;
385(11):1053-61.
PMID: 22976830
The participation of the chemokine CCL2 (monocyte chemoattractant protein-1) in inflammatory and neuropathic pain is well established. Furthermore, the release of CCL2 from a NCTC 2472 cells-evoked tumor and its...
18.
Ponsati B, Carreno C, Curto-Reyes V, Valenzuela B, Duart M, Van den Nest W, et al.
J Pharmacol Exp Ther
. 2012 Mar;
341(3):634-45.
PMID: 22393248
Small peptides patterned after the N terminus of the synaptosomal protein of 25 kDa, a member of the protein complex implicated in Ca(2+)-dependent neuronal exocytosis, inhibit in vitro the release...
19.
Baamonde A, Hidalgo A, Menendez L
Neurosci Lett
. 2011 Aug;
502(3):178-81.
PMID: 21827829
We study here the involvement of excitatory amino acid receptors, glial cell activation and IL-1β release in the spinal hyperalgesia evoked by the chemokine CCL2 (MCP-1). Three hours after the...
20.
Curto-Reyes V, Boto T, Hidalgo A, Menendez L, Baamonde A
Eur J Pharmacol
. 2011 Jul;
668(1-2):184-9.
PMID: 21771590
The stimulation of spinal cannabinoid type 2 (CB(2)) receptors is a suitable strategy for the alleviation of experimental pain symptoms. Several reports have described the up-regulation of spinal cannabinoid CB(2)...